Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources

Social Science and Medicine

Volumn 57, Issue 11, 2003, Pages 2207-2215

  Sendi, Pedram ^a,c   Al, Maiwenn J ^a   Gafni, Amiram ^b   Birch, Stephen ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cost effectiveness analysis; Portfolio; Resource constraints; Sensitivity analysis; Uncertainty

Indexed keywords

HEALTH CARE;

ARTICLE; BUDGET; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH PROGRAM; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; RESOURCE ALLOCATION; RESOURCE MANAGEMENT;

EID: 0141682087     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(03)00086-8     Document Type: Article

References (13)

1. Birch S., Gafni A. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? Journal of Health Economics. 11(3):1992;279-296.
2. Birch S., Gafni A. Changing the problem to fit the solution. Johannesson and Weinstein's (mis) application of economics to real world problems Journal of Health Economics. 12(4):1993;469-476.
3. Bridges J.F.P., Stewart M., King M.T., van Gool K. Adapting portfolio theory for the evaluation of multiple investments in health with a multiplicative extension for treatment synergies. European Journal of Health Economics. 3:2002;47-53.
4. Gafni A., Birch S. Guidelines for the adoption of new technologies. A prescription for uncontrolled growth in expenditures and how to avoid the problem Canadian Medical Association Journal. 148(6):1993;913-917.
5. O'Brien B.J., Sculpher M.J. Building uncertainty into cost-effectiveness rankings. Portfolio risk-return tradeoffs and implications for decision rules Medical Care. 38:2000;460-468.
6. Sendi P., Gafni A., Birch S. Opportunity costs and uncertainty in the economic evaluation of health care interventions. Health Economics. 11(1):2002;23-31.
7. Sendi P.P., Craig B.A., Meier G., Pfluger D., Gafni A., Opravil M., Battegay M., Bucher H.C. Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 44(6):1999;811-817.
8. Stinnett A.A., Mullahy J. Net health benefits. A new framework for the analysis of uncertainty in cost-effectiveness analysis Medical Decision Making. 18(2):1998;S68-S80.
9. Stinnett A.A., Paltiel A.D. Mathematical programming for the efficient allocation of health care resources. Journal of Health Economics. 15(5):1996;641-653.
10. Tambour M., Zethraeus N., Joahnnesson M. A note on confidence intervals in cost-effectiveness analysis. International Journal of Technology Assessment in Health Care. 14(3):1998;467-471.
11. van Hout B.A., Al M.J., Gordon G.S., Rutten F.F. Costs, effects and C/E-ratios alongside a clinical trial. Health Economics. 3(5):1994;309-319.
12. Weinstein M.C. From cost-effectiveness ratio to resource allocation, where to draw the line? Sloan F.A. Valuing health care: costs, benefits and effectiveness of pharmaceuticals and other medical technologies. 1995;77-97 Cambridge University Press, Cambridge.
13. Whitmore G.A., Findlay M.C. Stochastic dominance. 1978;Lexington Books, DC Heath and Company, Lexington, MA, USA.